The obesity epidemic continues to affect millions of Americans, with approximately two-thirds of the population classified as overweight or obese.[1] Individuals who are overweight or have obesity are more likely to develop type 2 diabetes (T2D), though not everyone with excess weight develops the condition.[2] For non-diabetics seeking support with weight loss, semaglutide has gained significant attention
Research Design 2.2.1
Rybelsus (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for the treatment of type 2 diabetes mellitus only, not for weight loss
Equally unsurprising is the demand for protein, something 29% of consumers wish to increase their intake of
The safety profile of GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonists has been extensively studied in both diabetes and obesity populations, with generally favorable long-term safety data
Here's the recipe for success: Take your Semaglutide or Tirzepatide as prescribed (no cheating!) Eat like you love yourself (because you do, right?) Move your body like you're auditioning for a dance crew Stay hydrated (no, wine doesn't count) Get enough sleep (beauty rest is real, folks) If you want more details on how to become a weight loss wizard, check out our website